After an abnormal NIPT finding in a pregnant woman, a maternal-fetal medicine doctor orders a second NIPT, against recommendations.

This small branch played a big role in advancing evidence-based genetic testing, and its loss diminishes US leadership in public health, say supporters.

Join our in-person breakfast session during ASCO to explore real-world applications of genomic profiling in cancer care!

The Times has obtained a list of 53 Venezuelan men the Trump administration has put in a wartime prison built to hold Al Qaeda suspects.

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.

Conservative supporters of government deregulation want to do away with state-imposed licensing requirements, a move genetic counselors say will harm patients.

The proposal, purported to save $83 billion over a decade, is a "dagger in the heart of all patient advocacy nonprofits," said the head of a cancer patient support group.

A patient found to carry a BRCA1 pathogenic variant is not referred to a certified genetic counselor in her health system.

Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence.

Key policies introduced over the past 45 years have brought new research organizations and investors into the pharmaceutical R&D process, increasing industry’s market power relative to that of private...

The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.

News and reporting on ASH from Precision Medicine Online Precision Oncology

A neurologist orders the wrong genetic test for a patient experiencing peripheral neuropathy and doesn't realize it even upon seeing the report.

Parents are suing the defendants for negligent genetic counseling and testing that they allege precluded their ability to avoid having children with Duchenne.

Doctors are using limited guidance on screening and treatment approaches for transgender patients predisposed to cancer while considering patient preferences and treatment goals.

AI tools have impressive potential in personalizing treatments, but doctors are concerned about bias, generalizability, and the lack of prospective validation.

As the popularity of drugs like Ozempic and Mounjaro soar, researchers, doctors, biotechs, and diagnostic firms see a role for biomarkers to guide their use.